COREVALVE
Report
- Report Number
- 2025587-2014-00519
- Event Type
- Injury
- Date Received
- July 23, 2014
- Date of Event
- June 12, 2014
- Report Date
- December 22, 2014
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- NPT
- PMA / PMN Number
- P130021
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MI, US
- Reporter Occupation
- PHYSICIAN
Narratives
THE PRODUCT REMAINS IMPLANTED AND THEREFORE HAS NOT BEEN RETURNED TO MEDTRONIC. A SUPPLEMENTAL REPORT WILL BE FILED WHEN THE INVESTIGATION IS COMPLETED. (B)(4).
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
A DEVICE HISTORY REVIEW IS NOT REQUIRED AS THE EVENT DESCRIPTION DOES NOT INDICATE A POTENTIAL MANUFACTURING ISSUE. CONDUCTION DISTURBANCES ARE KNOWN POTENTIAL ADVERSE EFFECTS AND CAN BE RESOLVED WITH THE IMPLANT OF A PERMANENT PACEMAKER WITH THE RISK-BENEFIT RATIO IN FAVOR OF THE PAV. NO OTHER ADVERSE EFFECTS WERE REPORTED.
MEDTRONIC RECEIVED INFORMATION THAT COMPLETE HEART BLOCK WAS OBSERVED FOLLOWING THE IMPLANT OF THIS TRANSCATHETER BIOPROSTHETIC VALVE. A PERMANENT PACEMAKER WAS IMPLANTED THE FOLLOWING DAY. NO SUBSEQUENT ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 431498 | COREVALVE | AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED | NPT | MEDTRONIC HEART VALVES DIVISION | MCS-P3-943 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00086 YR | Required Intervention |